These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18451232)

  • 1. Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer.
    Brennan DJ; Rexhepaj E; O'Brien SL; McSherry E; O'Connor DP; Fagan A; Culhane AC; Higgins DG; Jirstrom K; Millikan RC; Landberg G; Duffy MJ; Hewitt SM; Gallagher WM
    Clin Cancer Res; 2008 May; 14(9):2681-9. PubMed ID: 18451232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer.
    Rexhepaj E; Jirstrom K; O'Connor DP; O'Brien SL; Landberg G; Duffy MJ; Brennan DJ; Gallagher WM
    BMC Cancer; 2010 Nov; 10():639. PubMed ID: 21092276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin subcellular localization in high-grade astrocytomas: simultaneous expression in both nucleus and cytoplasm is negative prognostic marker.
    Saito T; Arifin MT; Hama S; Kajiwara Y; Sugiyama K; Yamasaki F; Hidaka T; Arita K; Kurisu K
    J Neurooncol; 2007 Apr; 82(2):193-8. PubMed ID: 17151933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.
    Bria E; Visca P; Novelli F; Casini B; Diodoro MG; Perrone-Donnorso R; Botti C; Sperduti I; Facciolo F; Milella M; Cecere FL; Cognetti F; Mottolese M
    Eur J Surg Oncol; 2008 May; 34(5):593-8. PubMed ID: 17693049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of nuclear survivin expression in resected adenoid cystic carcinoma of the head and neck.
    Ko YH; Roh SY; Won HS; Jeon EK; Hong SH; Lee MA; Kang JH; Hong YS; Kim MS; Jung CK
    Head Neck Oncol; 2010 Oct; 2():30. PubMed ID: 21034499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma.
    Kitamura H; Torigoe T; Hirohashi Y; Asanuma H; Inoue R; Nishida S; Tanaka T; Masumori N; Sato N; Tsukamoto T
    Virchows Arch; 2013 Jan; 462(1):101-7. PubMed ID: 23179762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer.
    Preuss SF; Weinell A; Molitor M; Stenner M; Semrau R; Drebber U; Weissenborn SJ; Speel EJ; Wittekindt C; Guntinas-Lichius O; Hoffmann TK; Eslick GD; Klussmann JP
    Br J Cancer; 2008 Feb; 98(3):627-32. PubMed ID: 18212752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of survivin and clinical correlation in patients with breast cancer.
    Sohn DM; Kim SY; Baek MJ; Lim CW; Lee MH; Cho MS; Kim TY
    Biomed Pharmacother; 2006 Jul; 60(6):289-92. PubMed ID: 16876381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic relevance of survivin in pancreatic endocrine tumors.
    Ekeblad S; Lejonklou MH; Stålberg P; Skogseid B
    World J Surg; 2012 Jun; 36(6):1411-8. PubMed ID: 22089920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients.
    Hinnis AR; Luckett JC; Walker RA
    Br J Cancer; 2007 Feb; 96(4):639-45. PubMed ID: 17285125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nuclear and cytoplasmic expressions of survivin in glioma and their prognostic value].
    Pan Y; Hu WH; Xie D; Wu QL; Liu YH; Xiang J; Wu HX
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):325-9. PubMed ID: 17456361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin and caspase-3 expression in breast cancer: correlation with prognostic parameters, proliferation, angiogenesis, and outcome.
    Nassar A; Lawson D; Cotsonis G; Cohen C
    Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):113-20. PubMed ID: 18227733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder.
    Yin W; Chen N; Zhang Y; Zeng H; Chen X; He Y; Wang X; Zhou Q
    Mod Pathol; 2006 Nov; 19(11):1487-97. PubMed ID: 16892011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.
    Zhang M; Zhang X; Zhao S; Wang Y; Di W; Zhao G; Yang M; Zhang Q
    Target Oncol; 2014 Dec; 9(4):349-57. PubMed ID: 24233638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of survivin does not appear to influence breast cancer recurrence risk.
    Collin LJ; Cronin-Fenton DP; Ahern TP; Christensen KB; Damkier P; Hamilton-Dutoit S; Kjaersgaard A; Lauridsen KL; Yacoub R; Christiansen P; Sørensen HT; Lash TL
    Acta Oncol; 2019 Feb; 58(2):154-161. PubMed ID: 30351173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma.
    Kleinberg L; Flørenes VA; Silins I; Haug K; Trope CG; Nesland JM; Davidson B
    Cancer; 2007 Jan; 109(2):228-38. PubMed ID: 17167759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin expression and impact on head and neck cancer outcomes.
    Khan SA; Burke M; Zhu F; Yang DH; Dubyk C; Mehra R; Lango MJ; Ridge JA; Sher DJ; Burtness B
    Oral Oncol; 2021 Jan; 112():105049. PubMed ID: 33221541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers.
    Frolova N; Edmonds MD; Bodenstine TM; Seitz R; Johnson MR; Feng R; Welch DR; Frost AR
    Tumour Biol; 2009; 30(3):148-59. PubMed ID: 19609101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survivin is an independent prognostic marker for risk stratification of breast cancer patients.
    Span PN; Sweep FC; Wiegerinck ET; Tjan-Heijnen VC; Manders P; Beex LV; de Kok JB
    Clin Chem; 2004 Nov; 50(11):1986-93. PubMed ID: 15364883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients.
    Tonini G; Vincenzi B; Santini D; Scarpa S; Vasaturo T; Malacrino C; Coppola R; Magistrelli P; Borzomati D; Baldi A; Antinori A; Caricato M; Nuzzo G; Picciocchi A
    Br J Cancer; 2005 Jun; 92(12):2225-32. PubMed ID: 15928668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.